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Abstract 
Background: Research has revealed the presence of somatic mutations in mitochondrial DNA (mtDNA) of certain 
types of tumours. As this has not been studied for canine mast cell tumours, the aim of this study was to identify 
mutations in the hypervariable region of mtDNA in mast cell tumours in dogs and determine their association with 
the process of neoplastic transformation.
Results: Samples from 17 dogs with histopathologically confirmed mast cell tumours were analysed. The samples 
consisted of tumour tissues (n = 17), normal tissues (n = 17), and blood (n = 17). Amplicons of the displacement loop 
(D‑loop) were sequenced and the obtained nucleotide sequences were subjected to bioinformatics analyses. Somatic 
mutations were detected in seven positions of the D‑loop nucleotide sequences in 47 % of the dogs, while poly‑
morphisms were identified in 94 % of the dogs. Most of these changes were homoplasmic, while heteroplasmy was 
detected in two individuals. Six new haplotypes were established as being characteristic for canine mast cell tumours. 
There was no association between the presence of the mutations and sex, haplotype, or malignancy grade assessed 
in 3 and 2‑grade scales.
Conclusions: Differences in the frequency of somatic mutations imply their direct association with the neoplastic 
transformation. However, their functional consequences and clinical significance are not clear. The mutations may be 
used for diagnosis and prognosis of canine mast cell tumours in the future.
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Findings
Mast cell tumours account for 7–21  % of all diagnosed 
skin neoplasms in dogs [1]. The aetiology of mast cell 
tumour development is not fully understood but recent 
research of human tumours has revealed the presence of 
somatic mutations in mitochondrial DNA (mtDNA), in 
particular in the D-loop region, which controls replica-
tion and transcription of mtDNA [2, 3].
Somatic cells contain hundreds to several thousand 
mitochondria, each containing 1–10 gene copies of 
mtDNA, which often undergoes spontaneous mutations 
due to their lack of protective activity of histones, the 
globular, coiled structure of mtDNA and a high level of 
mitochondrial reactive oxygen species (ROS). When a 
cell or tissue contains both mutated and normal wild-
type mtDNA, the condition is known as heteroplasmy, 
while homoplasmy refers to the presence of only one type 
of mtDNA (mutated or normal mtDNA). Most changes 
within the mtDNA nucleotide sequences of neoplastic 
cells are homoplastic [3].
Investigations of the association between mtDNA 
somatic mutations and neoplastic transformation have 
primarily been conducted in humans [2–4] where 
somatic mtDNA mutations have been found in malig-
nant tumours such as prostate and breast cancer. Such 
mutations are considered to trigger the neoplastic 
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transformation through shifts of cell energy resources, 
an increase in the mitochondrial oxidative stress, and 
modulation of apoptosis [3]. Only a few studies have 
been carried out on canine tumours [5–9]. Bertagnolli 
et  al. [5] investigated mixed canine mammary tumours 
and performed an analysis of a fragment of the D-loop of 
mtDNA from epithelial and mesenchymal tumour com-
ponents. They identified nucleotide changes that could 
serve as molecular markers for establishing the origin 
of neoplastic cells. An association between a nuclear 
and/or mtDNA mutation and malignant transformation 
has been observed for canine tumours in other studies 
[6–9]. Slaska et al. [7, 8] observed somatic mutations in 
the D-loop region of mtDNA in 62  % of examined epi-
thelial tumours and in 25 % of mesenchymal tumours. In 
another study, no mutations in mesenchymal tumours 
were been found, whereas 50  % of epithelial tumours 
exhibited somatic mutations. Blood and tumour hetero-
plasmy in the D-loop region has been diagnosed in dogs 
with squamous cell carcinoma, comedo carcinoma of the 
mammary gland, and sweat gland carcinoma [7, 8].
Besides the D-loop, three mtDNA genes, i.e. the NADH 
dehydrogenase subunit 1 (ND1), cytochrome c oxidase 
subunit I (COI), and cytochrome b (CYTB) have been 
analysed in different canine tumour types. The results 
showed that polymorphisms in these genes influenced 
the function of proteins and thus their potential role in 
carcinogenesis [9].
Presence of mtDNA defects in canine mast cell 
tumours has not been reported. The aim of this study 
was therefore to identify mutations in the hypervari-
able region of mtDNA in canine mast cell tumours and 
to assess their association with the process of neoplastic 
transformation.
Complete sets of tumour tissues, normal skin tissues 
and blood (n  =  17) were obtained from 17 dogs with 
mast cell tumours that had undergone surgery. Normal 
and tumour tissues were sampled for histopathology 
and were fixed in buffered formalin, pH = 7.2, processed 
routinely, embedded in paraffin wax, sectioned at 4  µm 
and stained with haematoxylin-eosin and toluidine blue. 
Microscopic classification was performed in accordance 
with the WHO histological classification [10]. The degree 
of malignancy was assessed using both a 3-grade scale 
[11] and a 2-grade scale [12]. The dogs were divided into 
three groups according to age: I (up to 5 years), II (from 6 
to 9 years), and III (over 10 year-old).
DNA was extracted from tissues and blood with the 
DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany). 
DNA samples were assessed quantitatively and quali-
tatively by electrophoretic separation in agarose gel 
and spectrophotometrically by measurements of sam-
ple absorbance in a BioPhotometer spectrophotometer 
(Eppendorf, Hamburg, Germany). Amplification of the 
D-loop was performed, using a polymerase chain reac-
tion (PCR) technique in a T100 Thermal Cycler (Bio-Rad, 
Wroclaw, Poland). Primer sequences used in the analysis, 
encompassing a mtDNA fragment between nucleotide 
15746–16107 (LF 5′- CATACTAACGTGGGGGTTAC; 
HR 5′- CCATTGACTGAATAGCACCTTG), were based 
on already published data [13]. The annealing tempera-
ture (Ta-60.8  °C) and amplification conditions were 
established experimentally. Amplification products were 
visualized on 2 % agarose gel. Amplicons were sequenced 
using a BigDye Terminator Cycle Sequencing kit (Applied 
Biosystem, Foster City, CA, USA) in GeneAmp PCR sys-
tem 9700 (Applied Biosystem). The samples were subse-
quently purified on CentriSep columns according to the 
manufacturer’s protocol or precipitated with ethanol and 
sodium acetate according to the protocol of the BigDye 
kit manufacturer. Extension products were separated on 
an ABI 377 automated sequencer (Applied Biosystem).
The obtained nucleotide sequences were subjected 
to bioinformatics analyses in order to determine muta-
tion and polymorphic sites within the mtDNA frag-
ment of each sample (DNA Baser Sequence Assembler 
v 3.2). The D-loop nucleotide sequences were compared 
to the reference sequence [GenBank: U96639] [14, 15] 
and described as the polymorphisms. The hypervariable 
region I (HVI) dog haplotypes were established accord-
ing to Savolainen et al. [16], Pereira et al. [17], and Imes 
et al. [18].
The probability of the presence of a mutation in 
each locus in relation to the age, sex, haplotype, and 
malignancy grade was estimated using the method of 
least-squares means (lsm) ± standard error (se). The cor-
relation between the data was analysed using the SAS 9.4 
procedure PROC GLM (SAS Institute, Cary, NC, USA). 
Correlations with P ≤ 0.05 were considered significant.
The study was approved by the II Local Ethical Com-
mission for Animal Experiments in Lublin, Poland (Reso-
lution number 6/2013).
Data on sex, breed, age and malignancy grade of the 
dogs are presented in Table  1. Mutations and/or poly-
morphisms were observed in eight positions of the 
D-loop nucleotide sequences in all cases (n  =  17) of 
mast cell tumours (Tables  2, 3). Somatic mutations in 
seven positions of the D-loop nucleotide sequences were 
detected in 47 % of the dogs (Table 2). All changes were 
substitution mutations, i.e. exchange of one nucleotide 
base with another. These mutations were detected in 
the tumour tissue and blood, but not in the normal tis-
sues. The majority of the changes were homoplasmic. 
In one dog, heteroplasmy was detected in the blood and 
tumour in position m.C15815C/T (Table  2); in another 
dog, heteroplasmic changes were found only in the 
Page 3 of 6Śmiech et al. Acta Vet Scand  (2016) 58:28 
tumour in positions m.C15912T/C and m.C16025T/C 
(Fig.  1). Somatic mutations in tumour tissues in posi-
tions m.16003 (Fig. 2) and m.15912 mtDNA exhibited the 
highest frequency, in approximately 35 and 24  % of the 
cases, respectively. These mutations were also detected in 
the blood of one dog.
Recently reported tumour haplotypes (except B11) 
were present in tumour tissue but not in normal tis-
sue or blood (Table  2). The HVI dog haplotype A18, 
accounting for 41.7  % in normal tissue and blood, was 
the most prevalent haplotype in each type of the ana-
lysed tissues. In tumour tissue, it was present in 41.2 % 
Table 1 Data on dogs with mast cell tumours included in the study
Dog  
number
HVI dog  
haplotype
Sex Breed Age  
(years)
Grading according 
to Patnaik et al. [11], 
Kiupel et al. [12]
1 B1 F Dachshund 9 Grade III/high‑grade
2 A18 F Bavarian Mountain Hound 9 Grade III/high‑grade
3 A26 F St. Bernard 6 Grade II/high‑grade
4 B11 M French Bulldog 10 Grade II/low‑grade
5 B1 F Crossbreed 6 Grade I/low‑grade
6 A17 M Boxer 8 Grade I/low‑grade
7 B1 F Schnauzer 8 Grade II/low‑grade
8 A18 F Boxer 8 Grade II/low‑grade
9 A18 F Golden Retriever 4 Grade I/low‑grade
10 A18 F Central Asian 4 Grade II/high‑grade
11 A18 F Crossbreed 8 Grade II/low‑grade
12 A17 M Labrador 10 Grade II/low‑grade
13 A19 F Crossbreed 11 Grade II/low‑grade
14 A26 F Labrador 3,5 Grade II/low‑grade
15 A18 F Bernese Mountain Dog 8 Grade II/high‑grade
16 A18 F Crossbreed 15 Grade II/low‑grade
17 A18 F Bernese Mountain Dog 9 Grade III/high‑grade
Table 2 Somatic mutations in the D-loop sequence in normal tissue, blood and tumour tissue in cases of canine mast cell 
tumours
Somatic mutations in the D-loop sequence were present in 8 out of 17 dogs
* Recently reported haplotypes [16–18]






HVI haplotype  
(normal tissue → tumour tissue)
1 m.15815C m.15815C/T m.15815C/T B1 → B1/B37




3 m.15912C m.15912C m.15912T/C A26 → A101*/102*
m.16003A m.16003A m.16003G
m.16025C m.16025C m.16025T/C
4 m.15800 T m.15800 T m.15800 C B11* → A172*




6 m.15795C m.15795C m.15795T A17 → A173*
7 m.16003G m.16003G m.16003A B1 → B12*
13 m.16003A m.16003A m.16003G A19 → A191*
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of the tumours. The mtDNA haplotype was changed in 
all dogs with detected mutations; hence, six not previ-
ously reported haplotypes of mast cell tumours were 
detected. Compared to the reference canine sequence, 
polymorphisms (m.T15800C, m.C15814T, m.T15815C, 
m.C15912T, m.C15955T, m.A16003G, m.T16025C) were 
found in seven positions of the D-loop sequences in 16 
of 17 dogs (94  %) with mast cell tumours (Table  3). In 
most dogs (94 %) polymorphism was detected in position 
m.C15814T, while polymorphism at D-loop position 
m.C15955T was found in 35  % of the examined dogs 
(Table 3).
Mutations in loci m.15912 and m.16003 were only 
detected in dogs aged six year or older (age groups II 
and III). The risk of mutation in locus m.16003 was 
significantly higher in the oldest dogs (age group III) 
compared to the youngest dogs (P =  0.047). However, 
since the group sizes were limited, these data should be 
interpreted with care. Statistical analyses did not reveal 
an association between presence of mutations and sex, 
haplotype, or the tumour malignancy grades (Tables  1 
and 2).
Analysis of the D-loop sequences revealed a relatively 
high genetic variability. As the mutations occurred 
independently of the mast cell tumour malignancy 
grades, this indicates that the presence of mutations 
in the D-loop and the malignancy grade was not asso-
ciated. Mutations in the mtDNA sequences and sex 
or haplotype were not associated as also observed 
for other types of canine tumours [7–9]. Some of the 
observed mutations (except m.16003 and m.16025) have 
been recognized in other types of canine tumours previ-
ously [5]. These were mostly homoplasmic substitution 
mutations although single heteroplasmy mutations were 
found as well.
Table 3 Differences in  the mitochondrial D-loop region 
between the reference sequence and normal tissue, blood 
and  tumour tissue sequences in  cases of  canine mast cell 
tumours













1 m.15800T m.15800C m.15800C m.15800C
1–12, 14–17 m.15814C m.15814T m.15814T m.15814T
7 m.15815T m.15815C m.15815C m.15815C
1, 7 m.15912C m.15912T m.15912T m.15912T
1, 4–7, 12 m.15955C m.15955T m.15955T m.15955T
1 m.16003A m.16003G m.16003G m.16003G
14 m.16025T m.16025C m.16025C m.16025C
Fig. 1 Cancer heteroplasmy in position m.16025 (a normal tissue, b blood, c tumour tissue)
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Presence of mutations in the D-loop sequences in 
tumour tissue and/or blood of dogs with mast cell 
tumours indicates that they may be involved in the 
process of neoplastic transformation. Further studies 
on the significance of mtDNA D-loop mutations and 
their association with neoplastic transformation, bio-
logical behaviour, and histologic grade of canine mast 
cell tumour are however required to determine their 
significance.
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